| Literature DB >> 32184577 |
Zihe Peng1, Yuelin Yu1, Wei Wei2, Yongchun Hou2, Zhenyu Sun3, Ying Wang4, Lin Zhang5, Ying Zhou5, Qian Wang1, Yong Cai1.
Abstract
OBJECTIVE: The purpose of this article was to examine the validity and reliability of the LifeWindows Information-Motivation-Behavioral Skills Antiretroviral Therapy (ART) Adherence Questionnaire (LW-IMB-AAQ) among HIV+ patients in Shanghai.Entities:
Keywords: China; HIV; IMB model; reliability; validity
Year: 2020 PMID: 32184577 PMCID: PMC7062391 DOI: 10.2147/PPA.S234041
Source DB: PubMed Journal: Patient Prefer Adherence ISSN: 1177-889X Impact factor: 2.711
Demographic Characteristics of the Participants (N=426) and Their Relationship with ART Adherence
| N (%) | n in High Adherence Group (n/N%) | p | |
|---|---|---|---|
| Age | |||
| 18–40 | 259(60.8%) | 247(95.4%) | 0.867 |
| 41–60 | 111(26.1%) | 105(94.6%) | |
| 61–80 | 56(13.1%) | 54(96.4%) | |
| Sex | |||
| Male | 402(94.4%) | 383(95.3%) | 1 |
| Female | 24(5.6%) | 23(95.8%) | |
| Education | |||
| Primary school or below | 3(0.7%) | 3(100%) | 0.425 |
| Junior high school | 39(9.1%) | 36(92.3%) | |
| Senior high school | 86(20.2%) | 84(97.7%) | |
| College degree or above | 298(67.0%) | 283(95.0%) | |
| Marital Status | |||
| Single | 279(65.5%) | 268(96.1%) | 0.457 |
| Currently married | 104(24.4%) | 96(92.3%) | |
| Divorced | 38(8.9%) | 37(97.4%) | |
| Widowed | 5(1.2%) | 5(100%) | |
| Income, Yuan (0.15$)/Month | |||
| ≤3000 | 32(7.5%) | 30(93.8%) | 0.564 |
| 3000—6000 | 99(23.2%) | 92(92.9%) | |
| 6001—12,000 | 163(38.3%) | 157(96.3%) | |
| ≥12,000 | 132(31.0%) | 127(96.3%) | |
| Sexual Orientation | |||
| Heterosexual | 109(25.6%) | 107(98.2%) | 0.123 |
| Homosexual | 220(51.6%) | 210(95.5%) | |
| Bisexual | 52(12.2%) | 49(94.2%) | |
| Pansexual | 3(0.7%) | 3(100%) | |
| Unsure | 42(9.9%) | 37(88.1%) | |
| Transmission | |||
| Heterosexual | 76(17.8%) | 74(97.4%) | 0.201 |
| Homosexual | 233(54.7%) | 221(94.8%) | |
| Blood-borne | 7(1.6%) | 7(100%) | |
| Intravenous drug use | 2(0.5%) | 1(50%) | |
| Unknown | 108(25.4%) | 103(95.4%) | |
| Clinical Stage | |||
| HIV infection stage | 322(75.6%) | 307(95.3%) | 1 |
| AIDS stage | 104(24.4%) | 99(95.2%) | |
| Adherence | |||
| High | 406 (95.3%) | ||
| Low | 20 (4.7%) | ||
| Total | 426 | 406 |
The Mean Scores of Three Sections in Two Groups (N=426)
| High Adherence (n=406) Mean/SD | Low Adherence (n=20) Mean/SD | p | |
|---|---|---|---|
| Information | 3.71±2.868 | 2.50±1.987 | 0.016* |
| Motivation | 30.91±6.896 | 30.20±5.425 | 0.581 |
| Behavioral skills | 55.72±6.536 | 51.75±5.618 | 0.006** |
Notes: *p<0.05, **p<0.01.
Item Analysis for the LW-IMB-AAQ
| Item | Mean±SD | CR | p | Item-Total Correlation | p |
|---|---|---|---|---|---|
| Information | |||||
| 1 | 0.43±0.495 | 8.804 | <0.001 | 0.576 | <0.001 |
| 2 | 0.38±0.485 | 14.775 | <0.001 | 0.515 | <0.001 |
| 3 | 0.38±0.486 | 4.196 | 0.001 | 0.424 | <0.001 |
| 4 | 0.30±0.457 | 9.349 | <0.001 | 0.413 | <0.001 |
| 5 | 0.61±0.489 | 8.195 | <0.001 | 0.494 | <0.001 |
| 6 | 0.15±0.458 | 9.387 | <0.001 | 0.382 | <0.001 |
| 7 | 0.56±0.497 | 23.689 | <0.001 | 0.575 | <0.001 |
| 8 | 0.58±0.495 | 23.689 | <0.001 | 0.613 | <0.001 |
| 9 | 0.28±0.449 | 14.775 | <0.001 | 0.478 | <0.001 |
| Motivation | |||||
| 1 | 1.78±0.749 | 0.325 | 0.749 | 0.114 | 0.021 |
| 2 | 2.88±1.182 | 8.179 | <0.001 | 0.504 | <0.001 |
| 3 | 3.15±1.276 | 38.004 | <0.001 | 0.659 | <0.001 |
| 4 | 3.90±0.793 | 5.371 | <0.001 | 0.408 | <0.001 |
| 5 | 4.44±1.249 | 5.57 | <0.001 | 0.256 | <0.001 |
| 6 | 3.32±1.230 | 15.317 | <0.001 | 0.438 | <0.001 |
| 7 | 3.15±1.213 | 22.59 | <0.001 | 0.647 | <0.001 |
| 8 | 2.52±1.067 | 14.236 | <0.001 | 0.364 | <0.001 |
| 9 | 3.06±1.123 | 24.171 | <0.001 | 0.502 | <0.001 |
| 10 | 2.78±1.119 | 14.146 | <0.001 | 0.514 | <0.001 |
| Behavioral Skills | |||||
| 1 | 4.01±0.767 | 11.533 | <0.001 | 0.524 | <0.001 |
| 2 | 3.92±0.843 | 4.49 | <0.001 | 0.403 | <0.001 |
| 3 | 4.38±0.623 | 18.833 | <0.001 | 0.599 | <0.001 |
| 4 | 4.42±0.573 | 7.654 | <0.001 | 0.649 | <0.001 |
| 5 | 3.64±0.867 | 8.253 | <0.001 | 0.456 | <0.001 |
| 6 | 4.43±0.554 | 9.759 | <0.001 | 0.654 | <0.001 |
| 7 | 4.39±0.581 | 25.115 | <0.001 | 0.683 | <0.001 |
| 8 | 4.44±0.547 | 11.075 | <0.001 | 0.72 | <0.001 |
| 9 | 4.49±0.532 | 11.111 | <0.001 | 0.724 | <0.001 |
| 10 | 4.48±0.523 | 10.746 | <0.001 | 0.718 | <0.001 |
| 11 | 4.48±0.591 | 10.921 | <0.001 | 0.705 | <0.001 |
| 12 | 4.46±0.586 | 21.109 | <0.001 | 0.734 | <0.001 |
| 13 | 4.14±0.752 | 20.569 | <0.001 | 0.539 | <0.001 |
Abbreviation: CR, critical ratio.
The Reliability of the LW-IMB-AAQ
| α (n=426) | ICC (n=50) | Spearman–Brown Coefficient | |
|---|---|---|---|
| Information | 0.848 | 0.643*** | 0.825 |
| Motivation | 0.813 | 0.654*** | |
| Behavioral skills | 0.915 | 0.626*** | |
| Total | 0.889 | 0.799*** |
Notes: ***p<0.001, α, Cronbach’s α coefficients.
Abbreviation: ICC, interclass correlation coefficient
Exploratory Factor Analysis of the Questionnaire
| Subscales | |||
|---|---|---|---|
| Information | Subscale 1 | Subscale 2 | |
| 1: I know how each of my current HIV medications is supposed to be taken (for example whether or not my current medications can be taken with food, herbal supplements, or other prescription medications). | 0.609 | ||
| 2: I know what to do if I miss a dose of any of my HIV medications (for example, whether or not to take the pill (s) later). | 0.600 | ||
| 3: Skipping a few of my HIV medications from time to time would not really hurt my health. | 0.757 | ||
| 4: I know what the possible side effects of each of my HIV medications are. | 0.725 | ||
| 5: As long as I am feeling healthy, missing my HIV medications from time to time is OK. | 0.834 | ||
| 6: I understand how each of my HIV medications works in my body to fight HIV. | 0.787 | ||
| 7: If I do not take my HIV medications as prescribed, these kinds of medications may not work for me in the future. | 0.665 | ||
| 8: I believe that if I take my HIV medications as prescribed, I will live longer. | 0.600 | ||
| 9: I know how my HIV medications interact with alcohol and street drugs. | 0.745 | ||
| Motivation | Subscale 1 | Subscale 2 | Subscale 3 |
| 2: I get frustrated taking my HIV medications because I have to plan my life around them. | 0.771 | ||
| 3: I do not like taking my HIV medications because they remind me that I am HIV+. | 0.783 | ||
| 4: I feel that my healthcare provider takes my needs into account when making recommendations about which HIV medications to take. | 0.951 | ||
| 5: Most people who are important to me who know I am HIV positive support me in taking my HIV medications. | 0.924 | ||
| 6: My healthcare provider does not give me enough support when it comes to taking my medications as prescribed. | 0.509 | ||
| 7: It frustrates me to think that I will have to take these HIV medications every day for the rest of my life. | 0.808 | ||
| 8: I am worried that the HIV medications I have been prescribed will hurt my health. | 0.727 | ||
| 9: It upsets me that the HIV medications I have been prescribed can affect the way I look. | 0.779 | ||
| 10: It upsets me that the HIV medications I have been prescribed can cause side effects. | 0.829 | ||
| Behavioral skills | Subscale 1 | Subscale 2 | |
| 1: How hard or easy is it for you to stay informed about HIV treatment? | 0.780 | ||
| 2: How hard or easy is it for you to get the support you need from others for taking your HIV medications (for example, from friends, family, doctor, or pharmacist)? | 0.673 | ||
| 3: How hard or easy is it for you to get your HIV medication refills on time? | 0.697 | ||
| 4: How hard or easy is it for you to take your HIV medications when you are wrapped up in what you are doing? | 0.751 | ||
| 5: How hard or easy is it for you to manage the side effects of your HIV medications? | 0.747 | ||
| 6: How hard or easy is it for you to remember to take your HIV medications? | 0.798 | ||
| 7: How hard or easy is it for you to take your HIV medications because the pills are hard to swallow, taste bad, or make you sick to your stomach? | 0.852 | ||
| 8: How hard or easy is it for you to make your HIV medications part of your daily life? | 0.890 | ||
| 9: How hard or easy is it for you to take your HIV medications when your usual routine changes (for example, when you travel or when you go out with your friends)? | 0.903 | ||
| 10: How hard or easy is it for you to take your HIV medications when you do not feel good emotionally (for example, when you are depressed, sad, angry, or stressed out)? | 0.926 | ||
| 11: How hard or easy is it for you to take your HIV medications when you feel good physically and do not have any symptoms of your HIV disease? | 0.814 | ||
| 12: How hard or easy is it for you to take your HIV medications when you do NOT feel good physically? | 0.879 | ||
| 13: How hard or easy is it for you to talk to your health care provider about your HIV medications? | 0.633 | ||
Fitness of the LW-IMB-AAQ
| df | P | CFI | GFI | RMSEA | ||
|---|---|---|---|---|---|---|
| 7.476 | 7 | 0.381 | 1.068 | 0.999 | 0.995 | 0.013 |
Note: χ2, Minimum Fit Function.
Abbreviations: df, degree of freedom; CFI, Comparative Fit Index; GFI, Goodness of Fit Index; RMSEA, Root Mean Square Error of Approximation.
Convergent Validity and Discriminant Validity of the Questionnaire
| AVE | Subscales | ||
|---|---|---|---|
| Information | Knowledge | Effect | |
| Knowledge | 0.518 | 0.72 | |
| Effect | 0.486 | 0.620*** | 0.697 |
| Motivation | Personal | Social | |
| Personal | 0.557 | 0.746 | |
| Social | 0.904 | 0.148** | 0.951 |
| Behavioral skills | Self-efficacy | Objective abilities | |
| Self-efficacy | 0.505 | 0.711 | |
| Objective abilities | 0.701 | 0.424*** | 0.837 |
Notes: **p<0.01, ***p<0.001.
Abbreviations: AVE, average variance extracted; Knowledge, knowledge about ART and how to take it; Effect, the effect of ART on health; Personal, personal motivation; Social, social motivation; Self-efficacy, self-efficacy about insisting on taking ART; Objective abilities, objective abilities of using skills to improve ART adherence.